To help make the most out of a client's marketing spend, the preferred method is to utilize hard data, such as new patient starts, or prescription movement.
PARTNER | MEDACCESS
To help make the most out of a client's marketing spend, the preferred method is to utilize hard data, such as new patient starts, or prescription movement. These data are quantifiable and carry a strong degree of specificity. A secondary method for tracking success is to employ less direct forms of information, or soft data, such as AAU studies or unaided recall. While anecdotal, soft data can help agencies track trends in consumer knowledge and perceptions, and also can be invaluable for measuring the effectiveness of current marketing messages and campaigns. Another approach an agency can use to maximize a client's ROI while bringing value to the brand is to prioritize projects against sustainability. Invest in an initiative that can act as a cornerstone for other projects to extend the brand, as well as the bottom line. This process begins with a solid concept and on-target content that help to inform subsequent materials. When the initial idea soundly meets strategic objectives, each campaign element thereafter can lead to increased brand identity, as well as an extension of a client's dollar.
Didi Discar
Regarding patient compliance, messages to patients should promote disease awareness, as well as treatment facts—there is a medication that can help, it's readily accessible, and the therapy may make it easier for patients to cope with their disease, paving the way for a better quality of life. Making the connection between integrated managed markets and overarching brand messages can also leverage accessibility to medications.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.